20th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), Vienna, Austria, 26 - 29 August 2015, pp.105-110, (Full Text)
Introduction: Non-alcoholic fatty liver disease is associated with like other insulin resistance syndromes with obesity, hypertriglyceridemia, diabetes and hypertension metformin is known to restrict hepatic gluconeogenesis and reduces glycogenolysis.